Epidemic history and evolutionary dynamics of Hepatitis B virus infection in two remote communities in rural Nigeria

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Forbi, Joseph C ^a   Vaughan, Gilberto ^a   Purdy, Michael A ^a   Campo, David S ^a   Xia, Guo liang ^a   Ganova Raeva, Lilia M ^a   Ramachandran, Sumathi ^a   Thai, Hong ^a   Khudyakov, Yury E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AFRICA; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LAST COMMON ANCESTOR; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MICROBIAL POPULATION DYNAMICS; MOLECULAR EPIDEMIOLOGY; NIGERIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; RURAL POPULATION; SCHOOL CHILD; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS STRAIN; VIRUS TRANSMISSION; CLASSIFICATION; GENETICS; MIDDLE AGED; PATHOGENICITY; PHYLOGENY; VIROLOGY;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; NIGERIA; PHYLOGENY; RURAL POPULATION; YOUNG ADULT;

EID: 77955346625     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011615     Document Type: Article

References (65)

1. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, et al. (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34: 1329-1339.
2. Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733-1745.
3. Zanetti AR, Van Damme P, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26: 6266-6273.
4. Ganem D, Schneider RJ (2001) Hepadnaviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins. pp 2923-2969.
5. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, et al. (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
6. Kramvis A, Kew MC (2005) Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat 12: 456-464.
7. Norder H, Hammas B, Lee SD, Bile K, Courouce AM, et al. (1993) Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 74(Pt 7): 1341-1348.
8. Andernach IE, Hubschen JM, Muller CP (2009) Hepatitis B virus: the genotype E puzzle. Rev Med Virol 19: 231-240.
9. Bekondi C, Olinger CM, Boua N, Talarmin A, Muller CP, et al. (2007) Central African Republic is part of the West-African hepatitis B virus genotype E crescent. J Clin Virol 40: 31-37.
10. Hubschen JM, Andernach IE, Muller CP (2008) Hepatitis B virus genotype E variability in Africa. J Clin Virol 43: 376-380.
11. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, et al. (2004) Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 190: 400-408.
12. Andernach IE, Nolte C, Pape JW, Muller CP (2009) Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa. Emerg Infect Dis 15: 1222-1228.
13. Odemuyiwa SO, Mulders MN, Oyedele OI, Ola SO, Odaibo GN, et al. (2001) Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med Virol 65: 463-469.
14. Fasola FA, Kotila TR, Akinyemi JO (2008) Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria. Intervirology 51: 427-431.
15. Forbi JC, Onyemauwa N, Gyar SD, Oyeleye AO, Entonu P, et al. (2008) High prevalence of hepatitis B virus among female sex workers in Nigeria. Rev Inst Med Trop Sao Paulo 50: 219-221.
16. Olubuyide IO, Ola SO, Aliyu B, Dosumu OO, Arotiba JT, et al. (1997) Hepatitis B and C in doctors and dentists in Nigeria. Qjm 90: 417-422.
17. Beasley RP (2009) Rocks along the road to the control of HBV and HCC. Ann Epidemiol 19: 231-234.
18. Mast EE, Mahoney F, Kane M, Margolis HS (2004) Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccine 2004. Philadelphia: Saunders. pp 299-337.
19. Sadoh AE, Eregie CO (2008) Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization. Public Health 122: 1318-1320.
20. WHO (2005) WHO vaccine preventable diseases monitoring system, 2005 global summary Immunization profile-Nigeria.
21. Ramachandran S, Xia GL, Ganova-Raeva LM, Nainan OV, Khudyakov Y (2008) End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods 151: 217-224.
22. Nainan OV, Khristova ML, Byun K, Xia G, Taylor PE, et al. (2002) Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol 68: 319-327.
23. Tamura K, Nei M, Kumar S (2004) Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A 101: 11030-11035.
24. Kay A, Zoulim F (2007) Hepatitis B virus genetic variability and evolution. Virus Res 127: 164-176.
25. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, et al. (1987) Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 61: 3030-3034.
26. Bandelt HJ, Forster P, Rohl A (1999) Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16: 37-48.
27. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
28. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123: 585-595.
29. Fu YX (1996) New statistical tests of neutrality for DNA samples from a population. Genetics 143: 557-570.
30. Excoffier L, Laval G, Schneider S (2005) Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 1: 47-50.
31. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
32. Pupko T, Pe'er I, Shamir R, Graur D (2000) A fast algorithm for joint reconstruction of ancestral amino acid sequences. Mol Biol Evol 17: 890-896.
33. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
34. Zhou Y, Holmes EC (2007) Bayesian estimates of the evolutionary rate and age of hepatitis B virus. J Mol Evol 65: 197-205.
35. Newton MA, Raftery AE (1994) approximate bayesian inference by weighted likelihood bootstrap. Journal of the Royal Statistical Society, Series B 56: 3-48.
36. Kosakovsky S, Frost S, Muse S (2005) HyPhy: hypothesis testing using phylogenies. Bioinformatics 21: 676-679.
37. Kosakovsky S, Frost S (2005) Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21: 2531-2533.
38. Yang Z, Swanson W (2002) Codon-substitution models to detect adaptive evolution that account for heterogeneous selective pressures among site classes. Mol Biol Evol 19: 49-57.
39. Kosakovsky S, Frost S (2005) Not So Different After All: A Comparison of Methods for Detecting Amino Acid Sites Under Selection. Mol Biol Evol 22: 1208-1222.
40. Depla E, Van der Aa A, Livingston BD, Crimi C, Allosery K, et al. (2008) Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. J Virol 82: 435-450.
41. Kalidi I, Fofana Y, Rahly AA, Bochu V, Dehay C, et al. (1988) Study of HLA antigens in a population of Mali (West Africa). Tissue Antigens 31: 98-102.
42. Uko GP, Asuquo MA, Dawkins RL, Udim ER, Banjoko SO, et al. (1997) HLA class I phenotype and gene frequencies in parts of southern Nigeria. Dis Markers 13: 123-129.
43. Olinger CM, Venard V, Njayou M, Oyefolu AO, Maiga I, et al. (2006) Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 87: 1163-1173.
44. Kurbanov F, Tanaka Y, Fujiwara K, Sugauchi F, Mbanya D, et al. (2005) A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol 86: 2047-2056.
45. Makuwa M, Souquiere S, Telfer P, Apetrei C, Vray M, et al. (2006) Identification of hepatitis B virus subgenotype A3 in rural Gabon. J Med Virol 78: 1175-1184.
46. Kramvis A, Kew MC (2007) Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 37: S9-S19.
47. Kramvis A, Restorp K, Norder H, Botha JF, Magnius LO, et al. (2005) Full genome analysis of hepatitis B virus genotype E strains from South-Western Africa and Madagascar reveals low genetic variability. J Med Virol 77: 47-52.
48. Hawkins AE, Zuckerman MA, Briggs M, Gilson RJ, Goldstone AH, et al. (1996) Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank. J Virol Methods 60: 81-88.
49. Dreesman JM, Baillot A, Hamschmidt L, Monazahian M, Wend UC, et al. (2006) Outbreak of hepatitis B in a nursing home associated with capillary blood sampling. Epidemiol Infect 134: 1102-1113.
50. Isiugo-Abanihe UC (2006) Sociocultural aspects of HIV/AIDS infection in Nigeria. Afr J Med Med Sci 35 Suppl: 45-55.
51. Uwaezuoke SN, Nneli RO (2007) Death of a G-6-P-D deficient child with comorbid HIV infection linked to scarification. J Trop Pediatr 53: 62-63.
52. Garmiri P, Loua A, Haba N, Candotti D, Allain JP (2009) Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa. J Gen Virol 90: 2442-2451.
53. Alvarado Mora MV, Romano CM, Gomes-Gouvea MS, Gutierrez MF, Carrilho FJ, et al. (2010) Molecular epidemiology and genetic diversity of hepatitis B virus genotype E in an isolated Afro-Colombian community. J Gen Virol 91: 501-508.
54. Zaaijer HL, Bouter S, Boot HJ (2008) Substitution rate of the hepatitis B virus surface gene. J Viral Hepat 15: 239-245.
55. Drucker E, Alcabes PG, Marx PA (2001) The injection century: massive unsterile injections and the emergence of human pathogens. Lancet 358: 1989-1992.
56. Foege WH, Eddins DL (1973) Mass vaccination programs in developing countries. Prog Med Virol 15: 205-243.
57. Foege WH, Millar JD, Henderson DA (1975) Smallpox eradication in West and Central Africa. Bull World Health Organ 52: 209-222.
58. Herbert EW (1975) Smallpox inoculation in Africa. J Afr Hist 16: 539-559.
59. Patterson KD (1981) Health in colonial Ghana: disease, medicine and socioeconomic change 1900-1955. WalthamMassachusets: Cross Road Press.
60. Grischow JD, Morris KRS (2006) Tsetse eradication in the Gold Coast, 1928-51. Africa 76: 381-401.
61. Houillon D (1905) Variole et vaccine en Afrique Occidentale Franc ̧aise pour l'année 1903. Annales d'Hygiène et de Médecine Coloniale 8: 546-568.
62. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M (1999) Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 77: 789-800.
63. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, et al. (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355: 887-891.
64. Lehman EM, Wilson ML (2009) Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 16: 650-658.
65. Thompson SC, Goudey RE, Breschkin AM, Carnie J, Catton M (1997) Exposure to hepatitis B and C of tattooists in Victoria in 1984. J Viral Hepat 4: 135-138.